Your browser doesn't support javascript.
loading
Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
Sansone, E; Tiraboschi, M; Sala, E; Albini, E; Lombardo, M; Castelli, F; De Palma, G.
Afiliação
  • Sansone E; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
  • Tiraboschi M; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
  • Sala E; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
  • Albini E; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
  • Lombardo M; Chief Executive Office, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Castelli F; University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, 25123 Brescia, Italy.
  • De Palma G; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy. Electronic address: giuseppe.depalma@unibs.it.
J Infect ; 83(1): e17-e18, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33965428

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Evaluation_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Evaluation_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article